“In the past, evaluation of gait impairment has largely been subjective, instantaneous, and assessed in a laboratory. The use of BioStamp nPoint will allow researchers to monitor a patient’s gait continuously as they go about their daily lives enabling a better understanding of the patient’s health status.”

At the University of Vermont, Dr. McGinnis continues his work with the BioStamp system with research programs focused on developing new ways to track symptom progression in neurological disorders and measure human biomechanics outside of the laboratory.

“Movement disorders, particularly Huntington’s Disease, are understudied and need better characterization. I am hopeful that the outcomes of this collaboration will lead to a deeper understanding of gait pathology and progression in movement disorders with the potential to positively impact future therapies and the quality of life for patients with these conditions. I look forward to continuing to work with MC10 and the BioStamp nPoint system,” said Dr. McGinnis.

MC10 is headquartered in Lexington, MA.

About University of Vermont. Founded in 1791, the fifth oldest university in New England, the University of Vermont is a premier research university that places emphasis on undergraduate education.

The modern UVM is a public university that combines both strands of its history, offering students a liberal arts-style education in a research university setting.